Results 51 to 60 of about 9,181 (228)

Validation of the Milan Score Using Prolonged Wireless PH Monitoring

Alimentary Pharmacology &Therapeutics, EarlyView.
The Milan Score, a high‐resolution manometry‐derived tool, predicts pathological GERD on 96‐h wireless pH monitoring with high specificity and positive predictive value, maintaining robust discriminative performance across both typical and atypical symptom profiles and outperforming single HRM parameters as a standalone manometric parameter.
Stefano Siboni, Jiurgen Mema, Trevor McCarthy, Roberta De Maron, Matthew K. Schroeder, Marco Sozzi, Carlo Galdino Riva, Emanuele Asti, C. Prakash Gyawali   +8 more
wiley   +1 more source

"Drop in" gastroscopy outpatient clinic - experience after 9 months [PDF]

, 2012
Background Logistics handling referrals for gastroscopy may be more time consuming than the examination itself. For the patient, "drop in" gastroscopy may reduce uncertainty, inadequate therapy and time off work.
Gert Huppertz-Hauss, Lubomir Chengarov, Stein Dahler, Anita Jørgensen, Volker Moritz, Jørn Paulsen, Geir Hoff   +6 more
core   +2 more sources

P‐CAB vs. PPI for Upper Gastrointestinal Bleeding Prevention in Patients With Atherothrombotic Disease on Antithrombotic Therapy: A CDM Cohort Study

Alimentary Pharmacology &Therapeutics, EarlyView.
In patients with atherothrombotic disease on antithrombotic therapy, P‐CABs demonstrated a significantly superior protective effect against clinically significant upper GI haemorrhage compared to PPIs (aHR 0.22; p = 0.016). This real‐world study highlights P‐CABs as a more potent gastroprotective strategy for high‐risk populations requiring intensive ...
Min Joo Yoon, Soyoung Lee, Hye‐Kyung Jung, Min‐ho Kim, Suna Yu, Eui Sun Jeong, Chung Hyun Tae   +6 more
wiley   +1 more source

Prospective study on effect of Helicobacter pylori on gastroesophageal reflux disease [PDF]

Zanco Journal of Medical Sciences, 2017
Background and objective: The Helicobacter pylori infections role in etiology of peptic ulcer is well known, but its role in gastroesophageal reflux disease is one of the important issues which has to be confirmed.
Sabah Jalal Shareef
doaj   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

British Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman, Christopher J. Black, Andrea Shin, Daniel Keszthelyi   +3 more
wiley   +1 more source

Dysmotility in Esophageal Atresia: Pathophysiology, Characterization, and Treatment

Frontiers in Pediatrics, 2017
Esophageal dysmotility is almost universal after esophageal atresia (EA) repair and is mainly related to the developmental anomaly of the esophagus.
Christophe Faure, Franziska Righini Grunder   +1 more
doaj   +1 more source

Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia

Journal of Research in Medical Sciences, 2022
Background: Chronic dyspepsia's symptoms are frequently seen in primary to tertiary healthcare in Indonesia. This study aimed to describe the potential usability of pepsinogen (PG) values in determining gastric mucosal conditions, including superficial ...
Muhammad Miftahussurur, Langgeng Agung Waskito, Ari Fahrial Syam, Iswan Abbas Nusi, I Nyoman Dewa Wibawa, Yudith Annisa Ayu Rezkitha, Kartika Afrida Fauzia, Gontar Alamsyah Siregar, Fardah Akil, Bradley Jimmy Waleleng, Alexander Michael Joseph Saudale, Azzaki Abubakar, Hasan Maulahela, Marselino Richardo, Abdul Rahman, Yoma Sari Namara, Eko Sudarmo, Pangestu Adi, Ummi Maimunah, Poernomo Boedi Setiawan, Dalla Doohan, Tomohisa Uchida, Astri Dewayani, Purwo Sri Rejeki, Titong Sugihartono, Yoshio Yamaoka   +25 more
doaj   +1 more source

Management of Duodenal Ulcer with Gastroesophageal Reflux Disease (GERD) with Intravenous Pantoprazole [PDF]

, 2003
Proton pump inhibitors (PPIs) are the most effective anti secretory drugs available for controlling gastric acid acidity and volume. They are the drug of choice in the treatment for gastro esophageal reflux disease (GERD), Helicobacter pylori eradication,
Abdullah, M. (Murdani), Hardjodisasto, D. (Daldiyono), Makmun, D. (Dadang), Manan, C. (Chudahman), Simadibrata, M. (Marcellus), Syam, A. F. (Ari)   +5 more
core  

Rationalizing Proton Pump Inhibitor Use: Southeast Asia Consensus Recommendations

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim Proton pump inhibitors (PPIs) are integral to managing many gastrointestinal conditions. However, the prevalent inappropriate PPI prescription across Southeast Asia (SEA) is concerning. Given the absence of locally tailored recommendations to inform clinical practice, this consensus document aims to provide recommendations ...
Somchai Leelakusolvong, Tju Siang Chua, Duc Trong Quach, Andrew Ming‐Liang Ong, Ari Fahrial Syam, Augusto Jose G. Galang, Wee Kooi Cheah, Hang Viet Dao, Jose D. Sollano, Kalwinder Singh Khaira, Phuripong Kijdamrongthum, Rahela Ambaras Khan, Sakkarin Chirapongsathorn, Yeong Yeh Lee   +13 more
wiley   +1 more source

Peptic disease and Helicobacter pylori are highly prevalent in patients with the indeterminate form of chagas’ disease: report of 21 cases

Revista do Instituto de Medicina Tropical de São Paulo, 1997
Given that chagasic patients in the indeterminate form of this disease, can have abnormal motility of the digestive tract and immunologic abnormalities, we decided to assess the frequency of peptic disease and Helicobacter pylori (Hp) infection in these ...
Luiz Carlos Marques de OLIVEIRA, Abadia Gilda BUSO, Luiz SIQUEIRA FILHO, Flávia MORAES, Humberto Alves OLIVEIRA, Roseli Maria OLIVEIRA, Eliana Chaves SALOMÃO   +6 more
doaj